Major issues with JAMA neurology's Dhruva et al. study comparing spinal cord stimulation to conventional medical therapies
- PMID: 37434428
- DOI: 10.1111/papr.13270
Major issues with JAMA neurology's Dhruva et al. study comparing spinal cord stimulation to conventional medical therapies
Comment on
-
Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic Pain.JAMA Neurol. 2023 Jan 1;80(1):18-29. doi: 10.1001/jamaneurol.2022.4166. JAMA Neurol. 2023. PMID: 36441532 Free PMC article.
-
Issues in patient cohort, surrogate outcome measures and conflicts of interest of JAMA Neurology's Dhruva et al. propensity-matched retrospective evaluation of a single insurer administrative claims data of spinal cord stimulation compared with conventional medical therapy for chronic pain.Pain Pract. 2023 Jun;23(5):475-478. doi: 10.1111/papr.13213. Pain Pract. 2023. PMID: 37272239 No abstract available.
References
REFERENCES
-
- Dhruva SS, Murillo J, Ameli O, Morin PE, Spencer DL, Redberg RF, et al. Long- term outcomes in use of opioids, nonpharmacologic pain interventions, and total costs of spinal cord stimulators compared with conventional medical therapy for chronic pain. JAMA Neurol. 2022;80:18.
-
- Eldabe S, Gilligan C, Taylor R, Patel K, Duarti R. Issues in patient cohort, surrogate outcome measures and conflicts of interest of JAMA Neurology's Dhruva et al. propensity- matched retrospective evaluation of a single insurer administrative claims data of spinal cord stimulation compared with conventional medical therapy for chronic pain. Pain Pract. 2023;23:475-478. https://doi.org/10.1111/papr.13213
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
